Cargando…

Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.

We have developed a relative binding affinity-serum modified access (RBA-SMA) assay to determine the effect of serum on the access of xenoestrogens to estrogen receptors within intact cultured MCF-7 human breast cancer cells. We used this assay to predict low dose activity of two xenoestrogens in mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagel, S C, vom Saal, F S, Thayer, K A, Dhar, M G, Boechler, M, Welshons, W V
Formato: Texto
Lenguaje:English
Publicado: 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1469837/
https://www.ncbi.nlm.nih.gov/pubmed/9074884
_version_ 1782127695045328896
author Nagel, S C
vom Saal, F S
Thayer, K A
Dhar, M G
Boechler, M
Welshons, W V
author_facet Nagel, S C
vom Saal, F S
Thayer, K A
Dhar, M G
Boechler, M
Welshons, W V
author_sort Nagel, S C
collection PubMed
description We have developed a relative binding affinity-serum modified access (RBA-SMA) assay to determine the effect of serum on the access of xenoestrogens to estrogen receptors within intact cultured MCF-7 human breast cancer cells. We used this assay to predict low dose activity of two xenoestrogens in mice. In serum-free medium, bisphenol A, a component of polycarbonates and of resins used to line metal food cans, showed a lower relative binding affinity (RBA; 0.006%) than octylphenol (0.072%) and nonylphenol (0.026%), which are used as surfactants in many commercial products (all RBAs are relative to estradiol, which is equal to 100%). In 100% serum from adult men, bisphenol A showed a higher RBA (0.01%) than in serum-free medium and thus enhanced access to estrogen receptors relative to estradiol. In contrast, octylphenol showed a 22-fold decrease in RBA (0.0029%) and nonylphenol showed a 5-fold decrease in RBA (0.0039%) when measured in adult serum. This indicates that, relative to estradiol, serum had less of an inhibitory effect on the cell uptake and binding in MCF-7 cells of bisphenol A, while serum had a greater inhibitory effect on octylphenol and nonylphenol relative to estradiol. Extrapolation of these relative activities in adult serum predicted that the estrogenic bioactivity of bisphenol A would be over 500-fold greater than that of octylphenol in fetal mouse serum. Bisphenol A and octylphenol were fed to pregnant mice at 2 and 20 micrograms/kg/day. Exposure of male mouse fetuses to either dose of bisphenol A, but to neither dose of octylphenol, significantly increased their adult prostate weight relative to control males, which is consistent with the higher predicted bioactivity of bisphenol A than octylphenol in the RBA-SMA assay. In addition, our findings show for the first time that fetal exposure to environmentally relevant parts-per-billion (ppb) doses of bisphenol A, in the range currently being consumed by people, can alter the adult reproductive system in mice.
format Text
id pubmed-1469837
institution National Center for Biotechnology Information
language English
publishDate 1997
record_format MEDLINE/PubMed
spelling pubmed-14698372006-06-01 Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Nagel, S C vom Saal, F S Thayer, K A Dhar, M G Boechler, M Welshons, W V Environ Health Perspect Research Article We have developed a relative binding affinity-serum modified access (RBA-SMA) assay to determine the effect of serum on the access of xenoestrogens to estrogen receptors within intact cultured MCF-7 human breast cancer cells. We used this assay to predict low dose activity of two xenoestrogens in mice. In serum-free medium, bisphenol A, a component of polycarbonates and of resins used to line metal food cans, showed a lower relative binding affinity (RBA; 0.006%) than octylphenol (0.072%) and nonylphenol (0.026%), which are used as surfactants in many commercial products (all RBAs are relative to estradiol, which is equal to 100%). In 100% serum from adult men, bisphenol A showed a higher RBA (0.01%) than in serum-free medium and thus enhanced access to estrogen receptors relative to estradiol. In contrast, octylphenol showed a 22-fold decrease in RBA (0.0029%) and nonylphenol showed a 5-fold decrease in RBA (0.0039%) when measured in adult serum. This indicates that, relative to estradiol, serum had less of an inhibitory effect on the cell uptake and binding in MCF-7 cells of bisphenol A, while serum had a greater inhibitory effect on octylphenol and nonylphenol relative to estradiol. Extrapolation of these relative activities in adult serum predicted that the estrogenic bioactivity of bisphenol A would be over 500-fold greater than that of octylphenol in fetal mouse serum. Bisphenol A and octylphenol were fed to pregnant mice at 2 and 20 micrograms/kg/day. Exposure of male mouse fetuses to either dose of bisphenol A, but to neither dose of octylphenol, significantly increased their adult prostate weight relative to control males, which is consistent with the higher predicted bioactivity of bisphenol A than octylphenol in the RBA-SMA assay. In addition, our findings show for the first time that fetal exposure to environmentally relevant parts-per-billion (ppb) doses of bisphenol A, in the range currently being consumed by people, can alter the adult reproductive system in mice. 1997-01 /pmc/articles/PMC1469837/ /pubmed/9074884 Text en
spellingShingle Research Article
Nagel, S C
vom Saal, F S
Thayer, K A
Dhar, M G
Boechler, M
Welshons, W V
Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title_full Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title_fullStr Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title_full_unstemmed Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title_short Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
title_sort relative binding affinity-serum modified access (rba-sma) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol a and octylphenol.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1469837/
https://www.ncbi.nlm.nih.gov/pubmed/9074884
work_keys_str_mv AT nagelsc relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol
AT vomsaalfs relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol
AT thayerka relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol
AT dharmg relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol
AT boechlerm relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol
AT welshonswv relativebindingaffinityserummodifiedaccessrbasmaassaypredictstherelativeinvivobioactivityofthexenoestrogensbisphenolaandoctylphenol